Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Opko Health Inc (OPK)

Opko Health Inc (OPK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,773,100
  • Shares Outstanding, K 669,831
  • Annual Sales, $ 901,940 K
  • Annual Income, $ -314,930 K
  • 60-Month Beta 1.90
  • Price/Sales 3.20
  • Price/Cash Flow N/A
  • Price/Book 1.82
Trade OPK with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 0.04
  • Number of Estimates 3
  • High Estimate 0.05
  • Low Estimate 0.04
  • Prior Year -0.11
  • Growth Rate Est. (year over year) +136.36%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.21 +25.23%
on 09/29/20
4.76 -15.55%
on 10/19/20
+0.84 (+26.42%)
since 09/28/20
3-Month
2.84 +41.55%
on 09/04/20
6.02 -33.22%
on 07/30/20
-1.56 (-27.96%)
since 07/28/20
52-Week
1.12 +259.86%
on 04/03/20
6.47 -37.87%
on 07/21/20
+2.50 (+164.47%)
since 10/28/19

Most Recent Stories

More News
OPKO Health (OPK) to Report Q3 Earnings: What's in Store?

OPKO Health's (OPK) third-quarter results are likely to reflect solid performance from Products segment and RAYALDEE.

OPK : 3.98 (-3.86%)
PACB : 14.18 (-3.14%)
GWPH : 88.44 (-2.55%)
ZBH : 134.59 (-2.89%)
OPKO Health (OPK) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, OPKO Health (OPK) closed at $4.30, marking a +0.7% move from the previous day.

OPK : 3.98 (-3.86%)
OPKO Health's (OPK) BioReference Laboratories Unveils New Test

OPKO Health's (OPK) BioReference Laboratories' new multiplex test can differentiate between COVID-19 and Influenza infections with a single sample.

BDX : 237.20 (-2.88%)
DGX : 126.63 (-0.41%)
ABT : 106.34 (-2.06%)
OPK : 3.98 (-3.86%)
OPKO Health's BioReference Laboratories Launches Multiplex COVID-19 and Influenza A/B Test

, /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), is now accepting specimens for a new multiplex COVID-19 and influenza test for use by healthcare providers, clinics...

OPK : 3.98 (-3.86%)
OPKO Health (OPK) Outpaces Stock Market Gains: What You Should Know

OPKO Health (OPK) closed the most recent trading day at $4.30, moving +1.78% from the previous trading session.

OPK : 3.98 (-3.86%)
Global Prostate Cancer Diagnostics Market | Major Trends, Leading Players, Companies Analysis, Technological Innovations & Key Developments

DXD.VN : 0.040 (unch)
GHDX : 63.44 (-0.69%)
OPK : 3.98 (-3.86%)
SIEGY : 64.6500 (-6.33%)
More Stringent Testing is Planned in a Bid to Return to Normalcy

, /PRNewswire/ -- As the economy slowly resumes its activity, it is more important than ever to provide a vast and effective testing network across the country. With testing, various regulatory bodies...

TOMDF : 0.0406 (-19.60%)
CODX : 13.62 (-4.29%)
AYTU : 0.9545 (-3.59%)
CEMI : 4.74 (-5.58%)
OPK : 3.98 (-3.86%)
OPKO Health to Report Third Quarter 2020 Financial Results on October 29, 2020

OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended September 30, 2020, as well as discuss financial guidance, after the close of the U.S. financial...

OPK : 3.98 (-3.86%)
OPKO Health's BioReference Laboratories Launches COVID-19 Testing Program for New York City Schools

, /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ :OPK), today announced the beginning of its COVID-19 testing program for schools throughout the 2020-2021 school year...

OPK : 3.98 (-3.86%)
Notice of Class Action Settlement Involving Purchasers of OPKO Health, Inc. Common Stock during the period of September 26, 2013 through September 7, 2018

, /PRNewswire/ --

OPK : 3.98 (-3.86%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

OPKO Health is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development and commercialization expertise and novel and proprietary technologies.

See More

Key Turning Points

2nd Resistance Point 4.45
1st Resistance Point 4.30
Last Price 3.97
1st Support Level 4.03
2nd Support Level 3.91

See More

52-Week High 6.47
Fibonacci 61.8% 4.43
Last Price 3.97
Fibonacci 50% 3.79
Fibonacci 38.2% 3.16
52-Week Low 1.12

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar